Drugs

Title

Date Published

The effect of desmopressin on blood loss in patients with rheumatoid arthritis undergoing hip arthroplasty.

June 9, 2010

Safety of recombinant activated factor VII in patients with warfarin-associated hemorrhages of the central nervous system.

June 3, 2010

Role of factor VII in correcting dilutional coagulopathy and reducing re-operations for bleeding following non-traumatic major gastrointestinal and abdominal surgery.

June 2, 2010

A meta-analysis of the efficacy and safety of recombinant activated factor VII for patients with acute intracerebral hemorrhage without hemophilia.

June 1, 2010

Recombinant-activated factor VII for control and prevention of hemorrhage in nonhemophilic pediatric patients.

June 1, 2010

Recombinant activated factor VII in controlling bleeding in non-hemophiliac patients.

May 31, 2010

Intensive Menstrual Bleeding Successfully Treated With Recombinant Factor VIIa in Glanzmann Thrombasthenia.

May 11, 2010

The hemostatic profile of recombinant activated factor VII. Can low concentrations stop bleeding in off-label indications?

May 5, 2010

Optimizing on-demand treatment with NovoSeven room temperature stable.

May 1, 2010

Changing from aprotinin to tranexamic acid results in increased use of blood products and recombinant factor VIIa for aortic surgery requiring hypothermic arrest.

April 28, 2010

Peri-interventional control of haemostasis in a patient with combined coagulation factor V- and factor VIII-deficiency and anaphylaxis to fresh frozen plasma – a rare indication for recombinant factor VIIa.

April 12, 2010

A prospective, randomized, double-blinded single-site control study comparing blood loss prevention of tranexamic acid (TXA) to epsilon aminocaproic acid (EACA) for corrective spinal surgery.

April 6, 2010

Rate of inhibitor development in previously-untreated hemophilia a patients treated with plasma-derived or recombinant factor VIII concentrates. A systematic review.

March 16, 2010

Clinical efficacy and safety of the factor VIII/von Willebrand factor concentrate BIOSTATE in patients with von Willebrand’s disease: a prospective multi-centre study.

March 16, 2010

The efficacy of factor VIIa in emergency department patients with warfarin use and traumatic intracranial hemorrhage.

March 1, 2010

Activated recombinant factor VII (rFVIIa).

March 1, 2010

Pharmacological agents: antifibrinolytics and desmopressin.

March 1, 2010

Control of disseminated intravascular coagulation in Klippel-Trenaunay-Weber syndrome using enoxaparin and recombinant activated factor VIIa: a case report.

March 1, 2010

Giving tranexamic acid to reduce surgical bleeding in sub-Saharan Africa: an economic evaluation.

February 17, 2010

Recombinant factor VIIa for the correction of coagulopathy before emergent craniotomy in blunt trauma patients.

February 1, 2010